March 18, 2011
A federal judge in New Jersey Thursday rejected Orchid Chemicals & Pharmaceuticals Ltd.'s bid to toss one of the five Boniva patents Hoffmann-La Roche Inc. asserted to prevent Orchid from marketing a generic version of the osteoporosis treatment.